Ted Tan
Angel Investor @ Seeds Capital
Ted Tan is a seed investor at Seeds Capital focused on Medical and Nutrition. Mr. Ted Tan has over 30 years of public and private sector experience in policy making, programme development, leadership, coaching and mentoring, governance, and risk management.Formerly the Deputy CEO of Enterprise Singapore, an agency under the Singapore Ministry of Trade and Industry, Mr. Tan stood down in September 2021 and is now anEnterprise Fellow of Enterprise Singapore. Additionally, Mr. Tan is the Operating Partner of Heliconia Capital Management, a wholly owned subsidiary of Temasek Holdings that provides growth capital for SMEs.Mr. Tan is Chairman of Singapore based molecular diagnostics developer INEX Innovate, a Board Director of Singapore SGX Mainboard-listed Q&M Dental Group, and Board Director of China Life Insurance (Singapore) – a subsidiary of China Life Insurance Group, a Fortune 500 company. He is also the Chairman of IPI that catalyses innovation and Board Director of SEEDS Capital that invests in innovative startups.Mr. Tan has been appointed an Adjunct Associate Professor of the Nanyang Business School at Singapore’s Nanyang Technological University.In 2012, Mr. Tan was awarded the Public Administration Medal (Silver) by the Singapore government.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Ted Tan invests in
Stages Ted Tan invests in
Countries Ted Tan invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (33%)
- Nutrition 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
Stage
- Seed 2 (67%)
- Venture - Series Unknown 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
The Gentle Group
|
SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems. | $2M / Venture - Series Unknown / Jul 08, 2024 | |
Ligature Therapeutics
|
Ligature Therapeutics is an early-stage biotechnology company that develops small molecule “protein degrader” therapeutics.Ligature Therapeutics is an early-stage drug discovery company that takes a novel approach towards developing small molecules for targeted protein degradation to treat intractable diseases. Ligature Therapeutics was foundedby doctors Alvin Hung, Thomas Keller, and Congbao Kang with initial investment from Lightstone Singapore, a Singapore-focused venture fund founded in 2016 by Lightstone Ventures. | $6M / Seed / Jan 04, 2021 | |
|
The Gentle Group
|
SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems. | Seed / Jun 22, 2020 |
Co-Investors
About Seeds Capital
Seeds Capital is an investment arm of Enterprise Singapore that co-invests with independent investors in innovative startups. The firm was founded in 1992 and is headquartered in Central Region, Singapore.
Seeds Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kaixin Tan
General Manager
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ted Tan invest in?
Ted Tan invests primarily in Medical, Nutrition and Health Care startups, most often at Seed and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ted Tan?
Public channels for Ted Tan include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ted Tan last invest?
The most recent investment recorded for Ted Tan closed in Jul 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
